文献速递妇科产科

BGOG研究:机器人辅助腹腔镜治疗早期宫颈癌166例观察性结果

Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer.
PubMed 文献 · J Minim Invasive Gynecol · 2021-05-14

该研究为比利时与卢森堡妇科肿瘤组(BGOG)的前瞻性随访研究,纳入270例FIGO 2009 IA1-IB1期宫颈癌患者,其中166例接受机器人辅助腹腔镜手术并分析。3年无病生存率86%、5年85%;3年总生存率96%、5年91%,结论认为生存率至少与既往报道相似。

要点

  • 机器人辅助腹腔镜在早期宫颈癌中3年无病生存率86%、5年85%。
  • 3年总生存率96%、5年91%,中位随访44个月。
  • 84.9%为IB1期,71.7%为鳞癌,结果需等待RACC试验明确。

核心结论

  • BGOG研究显示早期宫颈癌机器人辅助腹腔镜术后无病生存和总生存率至少与既往报道的复发和生存数据相似。

研究设计与样本

  • 前瞻性随访研究,来自BGOG不同医院联合数据,纳入270例患者,其中166例适合分析。
  • 纳入FIGO 2009 IA1、IA2或IB1期宫颈癌,组织学为鳞癌、腺癌或腺鳞癌,均接受机器人辅助腹腔镜。

主要发现

  • 中位年龄45岁,84.9%为FIGO IB1期,71.7%为鳞癌,中位随访44个月(范围1-131个月)。
  • 3年无病生存率86%(95%CI 78.52-90.80),5年85%(95%CI 77.03-89.95)。
  • 3年总生存率96%(95%CI 90.11-98.22),5年91%(95%CI 82.54-95.17)。

临床怎么用

  • 对于早期宫颈癌(IA1-IB1期),机器人辅助腹腔镜可获得与既往报道相似的3年和5年生存率。
  • 临床决策需结合即将公布的RACC试验结果进一步明确机器人辅助腹腔镜的地位。

局限性

  • 为观察性研究,非随机对照,样本量有限(166例分析)。
  • 随访时间范围宽(1-131个月),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: Two recent studies (the Laparoscopic Approach to Cervical Cancer [LACC] trial and a cohort study based on the National Cancer Database) raise the question of whether minimally invasive surgery (conventional and robot-assisted laparoscopy) is inferior to open abdominal surgery in early-stage cervical cancer. In the laparotomy group of the LACC trial, the low rates of recurrence and death are notable. The present study wants to elucidate the current situation of patients with early-stage cervical cancer treated with robot-assisted laparoscopy in hospitals of the Belgium and Luxembourg Gynaecological Oncology Group (BGOG). DESIGN: This is a prospective follow-up study. SETTING: The combined data obtained from different BGOG hospitals were analyzed regarding patients similar to those included in the LACC trial in terms of cervical cancer recurrence and survival. PATIENTS: We included patients with stage IA1, IA2, or IB1 cervical cancer with a histologic subtype of squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma. INTERVENTIONS: All patients were treated with robot-assisted laparoscopy. MEASUREMENTS AND MAIN RESULTS: The outcomes were disease-free and overall survival at 3 and 5 years after surgery. A total of 270 patients were included, and 166 were found suitable for analysis. The median age was 45 years. Most patients had International Federation of Gynecology and Obstetrics stage IB1 cervical cancer (84.9%) and squamous cell carcinoma as the histologic subtype (71.7%). The median follow-up time was 44 months, with a range of between 1 and 131 months. Twenty-one recurrences and 12 deaths were noted. Of the deaths, 8 were related to cervical cancer. Disease-free survival was 86% at 3 years (95% confidence interval [CI], 78.52-90.80) and 85% at 5 years (95% CI, 77.03-89.95). Overall survival was 96% at 3 years (95% CI, 90.11-98.22) and 91% at 5 years (95% CI, 82.54 95.17). CONCLUSION: The results of this BGOG study show disease-free and overall survival rates after robot-assisted laparoscopy in early-stage cervical cancer that are at least similar to previous reported recurrence and survival data. We expect that the results of the Robot-assisted Approach to Cervical Cancer trial will elucidate the place of robot-assisted laparoscopy in early-stage cervical cancer.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. de Bruyn A, Peeters F, Smulders K, et al. Observational BGOG Study of the Results of Robot-assisted Laparoscopy in 166 Patients with FIGO 2009 Stage IA1-IB1 Cervical Cancer. J Minim Invasive Gynecol. 2021. PMID: 34000393. doi:10.1016/j.jmig.2021.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。